These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1280507)
101. Screening of blood donations for hepatitis C virus antibody. Kimber RJ Med J Aust; 1990 Jun; 152(11):613. PubMed ID: 2112223 [No Abstract] [Full Text] [Related]
102. Screening--sensitivity, specificity and hepatitis C. Stevenson EM; Thompson SC; Crofts N Med J Aust; 1996 Jul; 165(2):120. PubMed ID: 8692060 [No Abstract] [Full Text] [Related]
103. Different Detection Methods of Blood Nucleic Acid and Enzyme-linked Immunosorbent Assay for Blood Virus Screening. Ma Q; Xue J; Xin X; Mu N; Wu X; Yang B; Xu N; Du J Cell Mol Biol (Noisy-le-grand); 2022 Mar; 68(3):411-417. PubMed ID: 35988185 [TBL] [Abstract][Full Text] [Related]
104. Transfusion and Viral Hepatitis. Br Med J; 1950 Nov; 2(4688):1103-4. PubMed ID: 20787967 [No Abstract] [Full Text] [Related]
105. Pathogenesis of hepatitis C virus infection. Kohla M; Bonacini M Minerva Gastroenterol Dietol; 2006 Jun; 52(2):107-23. PubMed ID: 16557183 [TBL] [Abstract][Full Text] [Related]
106. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays. Widell A; Månsson AS; Sundström G; Hansson BG; Nordenfelt E J Med Virol; 1991 Dec; 35(4):253-8. PubMed ID: 1724983 [TBL] [Abstract][Full Text] [Related]
107. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland. Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225 [TBL] [Abstract][Full Text] [Related]
108. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients. Widell A; Sundström G; Hansson BG; Moestrup T; Nordenfelt E Vox Sang; 1991; 60(1):28-33. PubMed ID: 1647082 [TBL] [Abstract][Full Text] [Related]
109. Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay. Huang YY; Yang SS; Wu CH; Shih WS; Huang CS; Chen PH; Lin YM; Shen CT; Chen DS Transfusion; 1994 Aug; 34(8):661-5. PubMed ID: 7521077 [TBL] [Abstract][Full Text] [Related]
110. HCV and blood transfusion. Reesink HW; van der Poel CL; Cuypers HT; Lelie PN Arch Virol Suppl; 1992; 4():241-3. PubMed ID: 1280507 [TBL] [Abstract][Full Text] [Related]
111. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan. Yoshizawa H; Watanabe J Curr Stud Hematol Blood Transfus; 1994; (61):182-94. PubMed ID: 7525155 [No Abstract] [Full Text] [Related]
112. Hepatitis C virus infection from blood and blood products. van der Poel CL FEMS Microbiol Rev; 1994 Jul; 14(3):241-6. PubMed ID: 7522022 [TBL] [Abstract][Full Text] [Related]
113. [Demonstrating antibodies against hepatitis C virus in transfusion practice. Viral Hepatitis Working Group of the Société Française de la Transfusion Sanguine]. Maisonneuve P; Noël L Transfus Clin Biol; 1994; 1(5):397-400. PubMed ID: 7529098 [No Abstract] [Full Text] [Related]
114. Non-A, non-B hepatitis and the anti-HCV assay. Barbara JA; Contreras M Vox Sang; 1991; 60(1):1-7. PubMed ID: 1711260 [TBL] [Abstract][Full Text] [Related]